Journal article

Global policy and access to new hepatitis C therapies for people who inject drugs

Joseph S Doyle, Esther J Aspinall, Sharon J Hutchinson, Brendan Quinn, Charles Gore, Stefan Z Wiktor, Margaret E Hellard

INTERNATIONAL JOURNAL OF DRUG POLICY | ELSEVIER SCIENCE BV | Published : 2015

Abstract

People who inject drugs (PWID) are disproportionately affected by hepatitis C virus (HCV). This review outlines policy recommendations made in the 2014 World Health Organisation (WHO) Guidelines on Screening, Care and Treatment of HCV and their relevance to PWID. It also canvasses issues that will affect translation of these global guidelines into practice. The first global HCV guidelines released by WHO have recently advocated targeted HCV testing for PWID, assessment of liver disease and support for alcohol reduction during care. They also strongly advocate treatment using currently licensed direct-acting antiviral agents for all individuals, in particular PWID as a key affected population..

View full abstract

University of Melbourne Researchers